{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:41:05Z","timestamp":1740123665339,"version":"3.37.3"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1007\/s10875-023-01637-x","type":"journal-article","created":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T08:02:46Z","timestamp":1704182566000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Filaggrin-Associated Atopic Skin, Eye, Airways, and Gut Disease, Modifying the Presentation of X-Linked Reticular Pigmentary Disorder (XLPDR)"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-0368-1280","authenticated-orcid":false,"given":"Margaret W. Y.","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leslie","family":"Burnett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle T.","family":"Avery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tahereh","family":"Noori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilia","family":"Voskoboinik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parth R.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Artiene","family":"Tatian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stuart G.","family":"Tangye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul E.","family":"Gray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cindy S.","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,1,2]]},"reference":[{"issue":"1","key":"1637_CR1","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1002\/ajmg.1320100109","volume":"10","author":"MW Partington","year":"1981","unstructured":"Partington MW, Marriott PJ, Prentice RS, Cavaglia A, Simpson NE. Familial cutaneous amyloidosis with systemic manifestations in males. Am J Med Genet. 1981;10(1):65\u201375.","journal-title":"Am J Med Genet"},{"issue":"4","key":"1637_CR2","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1111\/j.1525-1470.1993.tb00396.x","volume":"10","author":"LC Ad\u00e8s","year":"1993","unstructured":"Ad\u00e8s LC, Rogers M, Sillence DO. An X-linked reticulate pigmentary disorder with systemic manifestations: report of a second family. Pediatr Dermatol. 1993;10(4):344\u201351.","journal-title":"Pediatr Dermatol"},{"issue":"2","key":"1637_CR3","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1111\/j.1525-1470.2005.22206.x","volume":"22","author":"RC Anderson","year":"2005","unstructured":"Anderson RC, Zinn AR, Kim J, Carder KR. X-linked reticulate pigmentary disorder with systemic manifestations: report of a third family and literature review. Pediatr Dermatol. 2005;22(2):122\u20136.","journal-title":"Pediatr Dermatol"},{"issue":"1","key":"1637_CR4","first-page":"102","volume":"18","author":"M Fernandez-Guarino","year":"2008","unstructured":"Fernandez-Guarino M, Torrelo A, Fernandez-Lorente M, Fraile G, Garc\u00eda-Sagredo JM, Ja\u00e9n P. X-linked reticulate pigmentary disorder: report of a new family. Eur J Dermatol. 2008;18(1):102\u20133.","journal-title":"Eur J Dermatol"},{"issue":"1","key":"1637_CR5","first-page":"85","volume":"16","author":"H M\u00e9garban\u00e9","year":"2005","unstructured":"M\u00e9garban\u00e9 H, Boehm N, Chouery E, Bernard R, Salem N, Halaby E, et al. X-linked reticulate pigmentary layer. Report of a new patient and demonstration of a skewed X-inactivation. Genet Couns. 2005;16(1):85\u20139.","journal-title":"Genet Couns."},{"issue":"6","key":"1637_CR6","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1002\/ajmg.a.35882","volume":"161a","author":"L Pezzani","year":"2013","unstructured":"Pezzani L, Brena M, Callea M, Colombi M, Tadini G. X-linked reticulate pigmentary disorder with systemic manifestations: a new family and review of the literature. Am J Med Genet A. 2013;161a(6):1414\u201320.","journal-title":"Am J Med Genet A."},{"issue":"2","key":"1637_CR7","doi-asserted-by":"publisher","first-page":"410","DOI":"10.5114\/ada.2022.115893","volume":"39","author":"YK Zhao","year":"2022","unstructured":"Zhao YK, Fan LH, Lu JF, Luo ZY, Lin ZM, Wang HJ, et al. X-linked reticulate pigmentary disorder in a 4-year-old boy. Postepy Dermatol Alergol. 2022;39(2):410\u20132.","journal-title":"Postepy Dermatol Alergol"},{"issue":"1","key":"1637_CR8","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1007\/s10875-020-00867-7","volume":"41","author":"C L\u00e9geret","year":"2021","unstructured":"L\u00e9geret C, Meyer BJ, Rovina A, Deigendesch N, Berger CT, Daikeler T, et al. JAK inhibition in a patient with X-linked reticulate pigmentary disorder. J Clin Immunol. 2021;41(1):212\u20136.","journal-title":"J Clin Immunol"},{"issue":"2","key":"1637_CR9","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/bjd.17327","volume":"180","author":"ZLZ Xu","year":"2019","unstructured":"Xu ZLZ. Image gallery: cutaneous findings in an adult with X-linked reticulate pigmentary disorder. Br J Dermatol. 2019;180(2):37.","journal-title":"Br J Dermatol"},{"issue":"4","key":"1637_CR10","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1080\/03014460701723912","volume":"43","author":"G Fraile","year":"2008","unstructured":"Fraile G, Norman F, Reguero ME, Defargues V, Redondo C. Cryptogenic multifocal ulcerous stenosing enteritis (CMUSE) in a man with a diagnosis of X-linked reticulate pigmentary disorder (PDR). Scand J Gastroenterol. 2008;43(4):506\u201310.","journal-title":"Scand J Gastroenterol"},{"issue":"8","key":"1637_CR11","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1001\/jamadermatol.2017.0046","volume":"153","author":"K Motaparthi","year":"2017","unstructured":"Motaparthi K, Hall B. Reticulate hyperpigmentation in a man with hypohidrosis and sinopulmonary infections. JAMA Dermatol. 2017;153(8):817\u20138.","journal-title":"JAMA Dermatol"},{"issue":"5","key":"1637_CR12","doi-asserted-by":"publisher","first-page":"e200","DOI":"10.1111\/bjd.15586","volume":"177","author":"P Starokadomskyy","year":"2017","unstructured":"Starokadomskyy P, Sifuentes-Dominguez L, Gemelli T, Zinn AR, Dossi MT, Mellado C, et al. Evolution of the skin manifestations of X-linked pigmentary reticulate disorder. Br J Dermatol. 2017;177(5):e200\u20131.","journal-title":"Br J Dermatol"},{"issue":"6","key":"1637_CR13","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1111\/pde.12646","volume":"32","author":"N Duman","year":"2015","unstructured":"Duman N, Ersoy-Evans S, G\u00f6k\u00f6z \u00d6. Reticulate pigmentation with systemic manifestations in a child. Pediatr Dermatol. 2015;32(6):871\u20132.","journal-title":"Pediatr Dermatol"},{"issue":"2","key":"1637_CR14","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s10875-020-00953-w","volume":"41","author":"P Starokadomskyy","year":"2021","unstructured":"Starokadomskyy P, Escala Perez-Reyes A, Burstein E. Immune dysfunction in Mendelian disorders of POLA1 deficiency. J Clin Immunol. 2021;41(2):285\u201393.","journal-title":"J Clin Immunol"},{"issue":"1","key":"1637_CR15","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/ajmg.1320520115","volume":"52","author":"AK Gedeon","year":"1994","unstructured":"Gedeon AK, Mulley JC, Kozman H, Donnelly A, Partington MW. Localisation of the gene for X-linked reticulate pigmentary disorder with systemic manifestations (PDR), previously known as X-linked cutaneous amyloidosis. Am J Med Genet. 1994;52(1):75\u20138.","journal-title":"Am J Med Genet"},{"issue":"5","key":"1637_CR16","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s00439-008-0498-4","volume":"123","author":"LJ Jaeckle Santos","year":"2008","unstructured":"Jaeckle Santos LJ, Xing C, Barnes RB, Ades LC, Megarbane A, Vidal C, et al. Refined mapping of X-linked reticulate pigmentary disorder and sequencing of candidate genes. Hum Genet. 2008;123(5):469\u201376.","journal-title":"Hum Genet"},{"issue":"5","key":"1637_CR17","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/ni.3409","volume":"17","author":"P Starokadomskyy","year":"2016","unstructured":"Starokadomskyy P, Gemelli T, Rios JJ, Xing C, Wang RC, Li H, et al. DNA polymerase-\u03b1 regulates the activation of type I interferons through cytosolic RNA:DNA synthesis. Nat Immunol. 2016;17(5):495\u2013504.","journal-title":"Nat Immunol"},{"issue":"5","key":"1637_CR18","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.ajhg.2019.03.006","volume":"104","author":"H Van Esch","year":"2019","unstructured":"Van Esch H, Colnaghi R, Freson K, Starokadomskyy P, Zankl A, Backx L, et al. Defective DNA polymerase \u03b1-primase leads to X-linked intellectual disability associated with severe growth retardation, microcephaly, and hypogonadism. Am J Hum Genet. 2019;104(5):957\u201367.","journal-title":"Am J Hum Genet"},{"issue":"4","key":"1637_CR19","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1111\/j.1365-4632.2010.04102.x","volume":"49","author":"BS Kim","year":"2010","unstructured":"Kim BS, Seo SH, Jung HD, Kwon KS, Kim MB. X-Linked reticulate pigmentary disorder in a female patient. Int J Dermatol. 2010;49(4):421\u20135.","journal-title":"Int J Dermatol"},{"issue":"1","key":"1637_CR20","doi-asserted-by":"publisher","first-page":"e187","DOI":"10.1002\/ski2.187","volume":"3","author":"H Jaffar","year":"2023","unstructured":"Jaffar H, Shakir Z, Kumar G, Ali IF. Ichthyosis vulgaris: an updated review. Skin Health Dis. 2023;3(1):e187.","journal-title":"Skin Health Dis"},{"issue":"2","key":"1637_CR21","doi-asserted-by":"publisher","first-page":"020501","DOI":"10.11613\/BM.2019.020501","volume":"29","author":"I \u010cepelak","year":"2019","unstructured":"\u010cepelak I, Dodig S, Pavi\u0107 I. Filaggrin and atopic march. Biochem Med (Zagreb). 2019;29(2):020501.","journal-title":"Biochem Med (Zagreb)"},{"issue":"6","key":"1637_CR22","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1111\/bjd.12219","volume":"168","author":"JP Thyssen","year":"2013","unstructured":"Thyssen JP, Godoy-Gijon E, Elias PM. Ichthyosis vulgaris: the filaggrin mutation disease. Br J Dermatol. 2013;168(6):1155\u201366.","journal-title":"Br J Dermatol"},{"issue":"4","key":"1637_CR23","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/ng1767","volume":"38","author":"CN Palmer","year":"2006","unstructured":"Palmer CN, Irvine AD, Terron-Kwiatkowski A, Zhao Y, Liao H, Lee SP, et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet. 2006;38(4):441\u20136.","journal-title":"Nat Genet"},{"key":"1637_CR24","doi-asserted-by":"publisher","first-page":"b2433","DOI":"10.1136\/bmj.b2433","volume":"339","author":"RA van den Oord","year":"2009","unstructured":"van den Oord RA, Sheikh A. Filaggrin gene defects and risk of developing allergic sensitisation and allergic disorders: systematic review and meta-analysis. BMJ. 2009;339:b2433.","journal-title":"BMJ"},{"issue":"2","key":"1637_CR25","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1586\/eci.11.100","volume":"8","author":"J Heimall","year":"2012","unstructured":"Heimall J, Spergel JM. Filaggrin mutations and atopy: consequences for future therapeutics. Expert Rev Clin Immunol. 2012;8(2):189\u201397.","journal-title":"Expert Rev Clin Immunol"},{"issue":"8","key":"1637_CR26","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/ng.3033","volume":"46","author":"LC Kottyan","year":"2014","unstructured":"Kottyan LC, Davis BP, Sherrill JD, Liu K, Rochman M, Kaufman K, et al. Genome-wide association analysis of eosinophilic esophagitis provides insight into the tissue specificity of this allergic disease. Nat Genet. 2014;46(8):895\u2013900.","journal-title":"Nat Genet"},{"issue":"7","key":"1637_CR27","doi-asserted-by":"publisher","first-page":"4033","DOI":"10.4049\/jimmunol.0903069","volume":"184","author":"C Blanchard","year":"2010","unstructured":"Blanchard C, Stucke EM, Burwinkel K, Caldwell JM, Collins MH, Ahrens A, et al. Coordinate interaction between IL-13 and epithelial differentiation cluster genes in eosinophilic esophagitis. J Immunol. 2010;184(7):4033\u201341.","journal-title":"J Immunol"},{"issue":"5","key":"1637_CR28","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1016\/j.jaci.2008.02.014","volume":"121","author":"S Weidinger","year":"2008","unstructured":"Weidinger S, O\u2019Sullivan M, Illig T, Baurecht H, Depner M, Rodriguez E, et al. Filaggrin mutations, atopic eczema, hay fever, and asthma in children. J Allergy Clin Immunol. 2008;121(5):1203-9.e1.","journal-title":"J Allergy Clin Immunol"},{"key":"1637_CR29","doi-asserted-by":"crossref","unstructured":"Moosbrugger-Martinz V, Leprince C, M\u00e9chin MC, Simon M, Blunder S, Gruber R, et al. Revisiting the roles of filaggrin in atopic dermatitis. Int J Mol Sci. 2022;23(10):5318.","DOI":"10.3390\/ijms23105318"},{"issue":"1","key":"1637_CR30","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.anai.2019.10.008","volume":"124","author":"C Drislane","year":"2020","unstructured":"Drislane C, Irvine AD. The role of filaggrin in atopic dermatitis and allergic disease. Ann Allergy Asthma Immunol. 2020;124(1):36\u201343.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"489","key":"1637_CR31","doi-asserted-by":"publisher","first-page":"eaat6177","DOI":"10.1126\/scitranslmed.aat6177","volume":"11","author":"MM Clark","year":"2019","unstructured":"Clark MM, Hildreth A, Batalov S, Ding Y, Chowdhury S, Watkins K, et al. Diagnosis of genetic diseases in seriously ill children by rapid whole-genome sequencing and automated phenotyping and interpretation. Sci Transl Med. 2019;11(489):eaat6177.","journal-title":"Sci Transl Med"},{"issue":"1","key":"1637_CR32","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1002\/ajmg.1320320125","volume":"32","author":"MW Partington","year":"1989","unstructured":"Partington MW, Prentice RS. X-linked cutaneous amyloidosis: further clinical and pathological observations. Am J Med Genet. 1989;32(1):115\u20139.","journal-title":"Am J Med Genet"},{"issue":"158","key":"1637_CR33","doi-asserted-by":"publisher","first-page":"200001","DOI":"10.1183\/16000617.0001-2020","volume":"29","author":"S Cazzato","year":"2020","unstructured":"Cazzato S, Omenetti A, Ravaglia C, Poletti V. Lung involvement in monogenic interferonopathies. Eur Respir Rev. 2020;29(158):200001.","journal-title":"Eur Respir Rev"},{"issue":"2","key":"1637_CR34","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/j.1365-2567.2009.03167.x","volume":"128","author":"FJ Culley","year":"2009","unstructured":"Culley FJ. Natural killer cells in infection and inflammation of the lung. Immunology. 2009;128(2):151\u201363.","journal-title":"Immunology"},{"key":"1637_CR35","doi-asserted-by":"crossref","unstructured":"Starokadomskyy P, Wilton KM, Krzewski K, Lopez A, Sifuentes-Dominguez L, Overlee B, et al. NK cell defects in X-linked pigmentary reticulate disorder. JCI Insight. 2019;4(21):e125688.","DOI":"10.1172\/jci.insight.125688"},{"issue":"1","key":"1637_CR36","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13073-021-00841-x","volume":"13","author":"AE Minoche","year":"2021","unstructured":"Minoche AE, Lundie B, Peters GB, Ohnesorg T, Pinese M, Thomas DM, et al. ClinSV: clinical grade structural and copy number variant detection from whole genome sequencing data. Genome Med. 2021;13(1):32.","journal-title":"Genome Med"},{"issue":"1","key":"1637_CR37","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s13059-016-0974-4","volume":"17","author":"W McLaren","year":"2016","unstructured":"McLaren W, Gil L, Hunt SE, Riat HS, Ritchie GRS, Thormann A, et al. The Ensembl variant effect predictor. Genome Biol. 2016;17(1):122.","journal-title":"Genome Biol"},{"issue":"7","key":"1637_CR38","doi-asserted-by":"publisher","first-page":"e1003153","DOI":"10.1371\/journal.pcbi.1003153","volume":"9","author":"U Paila","year":"2013","unstructured":"Paila U, Chapman BA, Kirchner R, Quinlan AR. GEMINI: integrative exploration of genetic variation and genome annotations. PLoS Comput Biol. 2013;9(7):e1003153.","journal-title":"PLoS Comput Biol"},{"issue":"1","key":"1637_CR39","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1093\/bioinformatics\/bty540","volume":"35","author":"V Gayevskiy","year":"2019","unstructured":"Gayevskiy V, Roscioli T, Dinger ME, Cowley MJ. Seave: a comprehensive web platform for storing and interrogating human genomic variation. Bioinformatics. 2019;35(1):122\u20135.","journal-title":"Bioinformatics"},{"issue":"5","key":"1637_CR40","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405\u201324.","journal-title":"Genet Med"},{"issue":"6","key":"1637_CR41","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1002\/humu.22981","volume":"37","author":"JT den Dunnen","year":"2016","unstructured":"den Dunnen JT, Dalgleish R, Maglott DR, Hart RK, Greenblatt MS, McGowan-Jordan J, et al. HGVS recommendations for the description of sequence variants: 2016 update. Hum Mutat. 2016;37(6):564\u20139.","journal-title":"Hum Mutat"},{"issue":"2","key":"1637_CR42","doi-asserted-by":"publisher","first-page":"100331","DOI":"10.1016\/j.gim.2022.10.013","volume":"25","author":"CF Wright","year":"2023","unstructured":"Wright CF, FitzPatrick DR, Ware JS, Rehm HL, Firth HV. Importance of adopting standardized MANE transcripts in clinical reporting. Genet Med. 2023;25(2):100331.","journal-title":"Genet Med"},{"issue":"8","key":"1637_CR43","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1007\/s10875-021-01141-0","volume":"41","author":"JY Yap","year":"2021","unstructured":"Yap JY, Moens L, Lin M-W, Kane A, Kelleher A, Toong C, et al. Intrinsic defects in B cell development and differentiation, T cell exhaustion and altered unconventional T cell generation characterize human adenosine deaminase type 2 deficiency. J Clin Immunol. 2021;41(8):1915\u201335.","journal-title":"J Clin Immunol"},{"key":"1637_CR44","doi-asserted-by":"publisher","first-page":"944","DOI":"10.3389\/fimmu.2017.00944","volume":"8","author":"PE Gray","year":"2017","unstructured":"Gray PE, Shadur B, Russell S, Mitchell R, Buckley M, Gallagher K, et al. Late-onset non-HLH presentations of growth arrest, inflammatory arachnoiditis, and severe infectious mononucleosis, in siblings with hypomorphic defects in UNC13D. Front Immunol. 2017;8:944.","journal-title":"Front Immunol"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-023-01637-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10875-023-01637-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-023-01637-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,31]],"date-time":"2024-01-31T10:19:13Z","timestamp":1706696353000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10875-023-01637-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["1637"],"URL":"https:\/\/doi.org\/10.1007\/s10875-023-01637-x","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"type":"print","value":"0271-9142"},{"type":"electronic","value":"1573-2592"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"29 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was carried out in accordance with the recommendations of Sydney Children\u2019s Hospital ethics committee with written informed consent from all subjects. All subjects gave written informed consent in accordance with the Declaration of Helsinki. The protocol was approved for CIRCA\u2014investigation of primary immunodeficiencies, by the Sydney Children\u2019s Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"The authors affirm that human research participants provided written informed consent for participation in this study in accordance with Sydney Children\u2019s Hospital Ethics Committee and the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"The authors affirm that human research participants provided informed consent for publication, including publication of the images in Figs.\u00a0,\u00a0, and .","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"38"}}